Julia TCW, PhD

Dr. Julia TCW received Ph.D. and A.M. in Molecular and Cellular Biology from Harvard University with research studies in induced pluripotent stem cell (iPSC) reprogramming in the Department of Stem Cell and Regenerative Biology. She then perused her postdoctoral research in the Department of Neuroscience, Ronald M. Loeb Center for Alzheimer’s Disease, Department of Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai, New York with a research focus of the development of iPSC models and study Alzheimer’s disease genetics. She achieved Druckenmiller Fellowship award from New York Stem Cell Foundation and K award from NIH. She is currently Assistant Professor in the Department of Pharmacology & Experimental Therapeutics and Director of Laboratory of Human Induced Pluripotent Stem Cell Therapeutics at Boston University School of Medicine in Boston. Dr. TCW’s laboratory is aiming at human induced pluripotent stem cell therapeutics. There are two main goals; 1) Deciphering functional mechanisms of Alzheimer’s disease genetics using in vitro iPSCs and in vivo iPSC/mouse Chimera models and 2) Developing in vitro model systems of human brain for drug screen. Recently, she has chosen for the 2022 Toffler Scholar Award for her proposal as the most futuristic research